36-Month Outcomes of Ahmed ClearPath ® Glaucoma Drainage Device in Severe Primary Open Angle Glaucoma.
Nithya BoopathirajIsabella V WagnerPaul Connor LentzLeticia ChecoEmily Aashna DorairajAbhimanyu S AhujaDarby D MillerSyril DorairajPublished in: Clinical ophthalmology (Auckland, N.Z.) (2024)
To our knowledge this is the first study to report 36-month outcomes of the novel ACP device in the treatment of refractory POAG. The safety profile and efficacy of the ACP was found to be comparable to that of other commonly utilized GDD models.